388 related articles for article (PubMed ID: 19472123)
1. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
Shaik AP; Jamil K; Das P
Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.
Ntais C; Polycarpou A; Ioannidis JP
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1395-402. PubMed ID: 14693728
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men.
Li M; Guan TY; Li Y; Na YQ
Chin Med J (Engl); 2008 Feb; 121(4):305-8. PubMed ID: 18304461
[TBL] [Abstract][Full Text] [Related]
4. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population.
Silig Y; Pinarbasi H; Günes S; Ayan S; Bagci H; Cetinkaya O
Cancer Invest; 2006 Feb; 24(1):41-5. PubMed ID: 16466991
[TBL] [Abstract][Full Text] [Related]
7. Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study.
Quiñones LA; Irarrázabal CE; Rojas CR; Orellana CE; Acevedo C; Huidobro C; Varela NE; Cáceres DD
Asian J Androl; 2006 May; 8(3):349-55. PubMed ID: 16625286
[TBL] [Abstract][Full Text] [Related]
8. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population.
Aktas D; Hascicek M; Sozen S; Ozen H; Tuncbilek E
Cancer Genet Cytogenet; 2004 Oct; 154(1):81-5. PubMed ID: 15381379
[TBL] [Abstract][Full Text] [Related]
9. Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses.
Zhuo WL; Zhang YS; Wang Y; Zhuo XL; Zhu B; Cai L; Chen ZT
Arch Med Res; 2009 Apr; 40(3):169-79. PubMed ID: 19427967
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between genetic polymorphisms of metabolizing enzymes and prostate cancer].
Gao JP; Huang YD; Yang GZ; Yang YQ
Zhonghua Nan Ke Xue; 2003 Feb; 9(1):32-5. PubMed ID: 12680328
[TBL] [Abstract][Full Text] [Related]
11. Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population.
Pandey SN; Choudhuri G; Mittal B
Eur J Cancer Prev; 2008 Apr; 17(2):77-81. PubMed ID: 18287863
[TBL] [Abstract][Full Text] [Related]
12. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
[TBL] [Abstract][Full Text] [Related]
13. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
Yao L; Yu X; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.
Dos Reis ST; Pontes J; Villanova FE; Borra PM; Antunes AA; Dall'oglio MF; Srougi M; Leite KR
J Urol; 2009 May; 181(5):2320-5. PubMed ID: 19303106
[TBL] [Abstract][Full Text] [Related]
15. [Polymorphism of metabolic gene and genetic susceptibility to prostate cancer].
Guan TY; Li M; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1467-70. PubMed ID: 16318816
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women.
Okobia M; Bunker C; Zmuda J; Kammerer C; Vogel V; Uche E; Anyanwu S; Ezeome E; Ferrell R; Kuller L
Breast Cancer Res Treat; 2005 Dec; 94(3):285-93. PubMed ID: 16254684
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
18. CYP1A1 polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population.
Sam SS; Thomas V; Reddy SK; Surianarayanan G; Chandrasekaran A
Head Neck; 2008 Dec; 30(12):1566-74. PubMed ID: 18767181
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.
Tanaka Y; Sasaki M; Shiina H; Tokizane T; Deguchi M; Hirata H; Hinoda Y; Okayama N; Suehiro Y; Urakami S; Kawakami T; Kaneuchi M; Pookot D; Igawa M; Okuyama A; Ishii N; Dahiya R
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):238-44. PubMed ID: 16492910
[TBL] [Abstract][Full Text] [Related]
20. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
Park K; Kim JH; Jeon HG; Byun SS; Lee E
Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
